Drugs with this side effect as MedDRA Preferred Term
- 1,25(OH)2D3
- 5-ASA
- Stevens-Johnson syndrome: postmarketing
- Benicar-HCT
- Erythema multiforme
- Stevens-Johnson syndrome
- CAS 76095-16-4
- Erythema multiforme
- Stevens-Johnson syndrome
- CAS 76420-72-9
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- Cancidas
- Erythema multiforme: postmarketing
- Diane-35
- Estrofem
- FAMP
- FK463
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- Gd-DTPA
- Ge-132
- Stevens-Johnson syndrome: postmarketing
- K779
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- L-Dmp
- Erythema multiforme: rare
- LY146032
- Stevens-Johnson syndrome: postmarketing
- Leuprorelin
- Lisinopril
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- Meropenem anhydrous
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- Mersyndol
- Nuvocid
- Oestrogen
- Erythema multiforme: very rare
- T-A2-3
- Erythema multiforme
- Stevens-Johnson syndrome
- Timentin
- Erythema multiforme
- Stevens-Johnson syndrome
- Triphasil
- Trisequens
- VACV
- Erythema multiforme: postmarketing
- Vancocine
- Stevens-Johnson syndrome: postmarketing
- abacavir
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- abacavir-lamivudine
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- acetaminophen
- acetazolamide
- actinomycin D
- Erythema multiforme
- Stevens-Johnson syndrome
- acyclovir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome
- albendazole
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- alendronate
- Stevens-Johnson syndrome: postmarketing
- aliskiren
- Stevens-Johnson syndrome: postmarketing, uncommon
- allopurinol
- Erythema multiforme
- Stevens-Johnson syndrome
- alogliptin
- Stevens-Johnson syndrome: postmarketing
- alprazolam
- Stevens-Johnson syndrome: postmarketing
- amifostine
- Erythema multiforme
- Stevens-Johnson syndrome
- amiodarone
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- amlodipine
- amlodipine besylate
- amoxicillin
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- amphetamine
- amphotericin B
- ampicillin
- amprenavir
- Stevens-Johnson syndrome: rare
- anastrozole
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- aprepitant
- Stevens-Johnson syndrome: postmarketing
- atazanavir
- Erythema multiforme
- Stevens-Johnson syndrome
- atorvastatin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- atovaquone
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- azathioprine
- Stevens-Johnson syndrome: very rare
- azithromycin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- aztreonam
- benazepril
- benazeprilat
- betahistine
- bezafibrate
- boceprevir
- Stevens-Johnson syndrome: postmarketing
- bortezomib
- Erythema multiforme
- Stevens-Johnson syndrome
- bosentan
- Erythema multiforme
- Stevens-Johnson syndrome
- bosutinib
- bumetanide
- bupropion
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- busulfan
- capecitabine
- captopril
- Erythema multiforme
- Stevens-Johnson syndrome
- carbamazepine
- Erythema multiforme: very rare
- Stevens-Johnson syndrome: very rare
- carvedilol
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefaclor
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefadroxil
- Erythema multiforme
- Stevens-Johnson syndrome
- cefazolin
- Erythema multiforme
- Stevens-Johnson syndrome
- cefdinir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefditoren
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefepime
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefixime
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefotaxime
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefotetan
- Erythema multiforme
- Stevens-Johnson syndrome
- cefoxitin
- Erythema multiforme
- Stevens-Johnson syndrome
- cefpodoxime
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefprozil
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- ceftazidime
- Erythema multiforme: very rare
- Stevens-Johnson syndrome: very rare
- ceftizoxime
- Erythema multiforme
- Stevens-Johnson syndrome
- ceftriaxone
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefuroxime
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cefuroxime axetil
- Erythema multiforme
- Stevens-Johnson syndrome
- celecoxib
- Erythema multiforme
- Stevens-Johnson syndrome
- cephalexin
- Erythema multiforme
- Stevens-Johnson syndrome
- cephem
- Stevens-Johnson syndrome: postmarketing
- cerivastatin
- Erythema multiforme
- Stevens-Johnson syndrome
- chlorambucil
- Erythema multiforme
- Stevens-Johnson syndrome
- chloroquine
- Erythema multiforme
- Stevens-Johnson syndrome
- chlorpropamide
- cidofovir
- Stevens-Johnson syndrome: postmarketing
- cilazapril
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cilostazol
- Stevens-Johnson syndrome: postmarketing
- cimetidine
- Erythema multiforme
- Stevens-Johnson syndrome
- cinoxacin
- Erythema multiforme
- Stevens-Johnson syndrome
- ciprofloxacin
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing, rare
- Erythema multiforme minor: very rare
- citalopram
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- cladribine
- Stevens-Johnson syndrome: rare
- clarithromycin
- Stevens-Johnson syndrome: postmarketing
- clindamycin
- Erythema multiforme
- Stevens-Johnson syndrome
- clindamycin phosphate
- Erythema multiforme
- Stevens-Johnson syndrome
- clobazam
- clofarabine
- Stevens-Johnson syndrome: postmarketing
- clomiphene citrate
- Erythema multiforme: postmarketing
- clopidogrel
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- clozapine
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- conjugated estrogens
- Erythema multiforme: postmarketing
- cyclophosphamide
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- d-telaprevir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome
- dalteparin
- danazol
- Erythema multiforme
- Stevens-Johnson syndrome
- darifenacin
- Erythema multiforme: postmarketing
- darunavir
- Erythema multiforme
- Stevens-Johnson syndrome
- dasatinib
- deferasirox
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- delavirdine
- Erythema multiforme
- Stevens-Johnson syndrome
- demeclocycline
- Erythema multiforme
- Stevens-Johnson syndrome
- desogestrel
- desvenlafaxine
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- diclofenac
- Erythema multiforme: very rare
- Stevens-Johnson syndrome: very rare
- diflunisal
- Erythema multiforme
- Stevens-Johnson syndrome
- diltiazem
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- docetaxel
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- doripenem
- Stevens-Johnson syndrome: postmarketing
- dorzolamide
- Stevens-Johnson syndrome: postmarketing
- doxorubicin
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- doxycycline
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- drospirenone (DRSP
- duloxetine
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- efavirenz
- Erythema multiforme: postmarketing, uncommon, 0% - 3.5%
- Stevens-Johnson syndrome: postmarketing, uncommon, 0% - 3.5%
- entacapone
- erlotinib
- erythromycin
- Erythema multiforme
- Stevens-Johnson syndrome
- erythromycin stearate
- Erythema multiforme
- Stevens-Johnson syndrome
- eslicarbazepine acetate
- Erythema multiforme
- Stevens-Johnson syndrome
- esomeprazole magnesium
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- estazolam
- estradiol
- Erythema multiforme: postmarketing
- estradiol cypionate
- estradiol valerate
- estriol
- estrone
- ethambutol
- Stevens-Johnson syndrome
- Erythema multiforme
- ethosuximide
- ethotoin
- etidronate
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- etodolac
- Erythema multiforme
- Stevens-Johnson syndrome
- etoposide
- etoposide phosphate
- etoricoxib
- Stevens-Johnson syndrome: postmarketing
- etravirine
- Erythema multiforme
- Stevens-Johnson syndrome
- exemestane
- ezetimibe
- Erythema multiforme: postmarketing
- famciclovir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- famotidine
- febuxostat
- Stevens-Johnson syndrome: postmarketing
- felbamate
- Stevens-Johnson syndrome: rare
- felodipine
- fenoprofen
- Stevens-Johnson syndrome: postmarketing
- fentanyl
- flucloxacillin
- Erythema multiforme: very rare
- Stevens-Johnson syndrome: very rare
- fluconazole
- Stevens-Johnson syndrome: postmarketing, rare
- fludarabine
- Erythema multiforme
- Stevens-Johnson syndrome
- flunisolide
- fluoxetine
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- fluphenazine decanoate
- flurbiprofen
- Erythema multiforme
- Stevens-Johnson syndrome
- fluvastatin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- fluvoxamine
- Stevens-Johnson syndrome: postmarketing
- fosamprenavir
- Stevens-Johnson syndrome: rare
- fosaprepitant
- fosaprepitant dimeglumine
- Stevens-Johnson syndrome: postmarketing
- foscarnet
- Erythema multiforme
- Stevens-Johnson syndrome
- fosinopril
- furosemide
- Erythema multiforme
- Stevens-Johnson syndrome
- gabapentin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- gadolinium
- gadopentetate
- Erythema multiforme: postmarketing
- gadoversetamide
- ganciclovir
- Stevens-Johnson syndrome: postmarketing
- gatifloxacin
- Stevens-Johnson syndrome: postmarketing
- gefitinib
- Erythema multiforme: 0.1%
- Stevens-Johnson syndrome
- gemcitabine
- Stevens-Johnson syndrome: very rare
- gemifloxacin
- Erythema multiforme: postmarketing
- gliclazide
- glimepiride
- Stevens-Johnson syndrome: postmarketing
- griseofulvin
- hepatitis B vaccines
- hetastarch
- Erythema multiforme: postmarketing
- hydrochlorothiazide
- Erythema multiforme
- Stevens-Johnson syndrome
- hydroxychloroquine
- Erythema multiforme
- Stevens-Johnson syndrome
- ibuprofen
- Erythema multiforme
- Stevens-Johnson syndrome
- icodextrin
- Erythema multiforme: postmarketing
- ifosfamide
- Stevens-Johnson syndrome: postmarketing
- imatinib
- Erythema multiforme: rare
- Stevens-Johnson syndrome: rare
- imiquimod
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome
- indapamide
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- indinavir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- indomethacin
- Erythema multiforme
- Stevens-Johnson syndrome
- iopromide
- Stevens-Johnson syndrome: postmarketing
- itraconazole
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- ivermectin
- Stevens-Johnson syndrome: postmarketing
- ixabepilone
- ketoconazole
- ketoprofen
- Erythema multiforme
- Stevens-Johnson syndrome
- ketorolac
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- ketorolac tromethamine
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- ketotifen
- Erythema multiforme
- Stevens-Johnson syndrome
- lacosamide
- Stevens-Johnson syndrome: postmarketing
- lamivudine
- Erythema multiforme
- Stevens-Johnson syndrome
- lamotrigine
- Erythema multiforme: rare
- Stevens-Johnson syndrome: rare, infrequent
- lansoprazole
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- leflunomide
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- lenalidomide
- Stevens-Johnson syndrome: postmarketing
- lercanidipine
- Erythema multiforme: rare
- Stevens-Johnson syndrome
- letrozole
- Erythema multiforme: very rare, postmarketing
- leuprorelin acetate
- levetiracetam
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- levobunolol
- lincomycin
- Erythema multiforme
- Stevens-Johnson syndrome
- linezolid
- Stevens-Johnson syndrome: postmarketing
- lisdexamfetamine dimesylate
- Stevens-Johnson syndrome: postmarketing
- lomefloxacin
- Stevens-Johnson syndrome: postmarketing
- loperamide
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- losartan
- Erythema multiforme
- Stevens-Johnson syndrome
- lovastatin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- lymecycline
- maprotiline
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- maraviroc
- Stevens-Johnson syndrome: postmarketing
- meclofenamate
- Erythema multiforme
- Stevens-Johnson syndrome
- medroxyprogesterone
- medroxyprogesterone acetate
- mefenamic acid
- Erythema multiforme
- Stevens-Johnson syndrome
- mefloquine
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- meloxicam
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- memantine
- Stevens-Johnson syndrome: postmarketing
- mephenytoin
- Erythema multiforme
- Stevens-Johnson syndrome
- meprobamate
- Erythema multiforme
- Stevens-Johnson syndrome
- meropenem
- Stevens-Johnson syndrome: postmarketing
- Erythema multiforme
- methazolamide
- Erythema multiforme
- Stevens-Johnson syndrome
- methotrexate
- Erythema multiforme
- Stevens-Johnson syndrome
- methsuximide
- methyclothiazide
- methylphenidate
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: postmarketing
- metolazone
- metronidazole
- mexiletine
- miconazole
- midodrine
- Erythema multiforme
- Stevens-Johnson syndrome
- milnacipran
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- minocycline
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- minoxidil
- mirabegron
- mirtazapine
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- modafinil
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- monomycin
- Erythema multiforme
- Stevens-Johnson syndrome
- montelukast
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- moxifloxacin
- Stevens-Johnson syndrome: postmarketing
- nabumetone
- Erythema multiforme
- Stevens-Johnson syndrome
- nalidixic acid
- Erythema multiforme
- Stevens-Johnson syndrome
- naproxen
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- nateglinide
- nefazodone
- Stevens-Johnson syndrome: postmarketing
- nefopam
- nelfinavir
- nevirapine
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing, uncommon, 0.3%
- nifedipine
- Erythema multiforme
- Stevens-Johnson syndrome
- nilotinib
- Erythema multiforme: uncommon
- nitrofurantoin
- Erythema multiforme
- Stevens-Johnson syndrome
- nitrogen mustard
- norethisterone
- norfloxacin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- nystatin
- ofatumumab
- Stevens-Johnson syndrome: postmarketing
- ofloxacin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- ogen
- omeprazole
- Erythema multiforme: postmarketing, rare, uncommon
- Stevens-Johnson syndrome: postmarketing, rare
- ondansetron
- Stevens-Johnson syndrome: postmarketing
- oseltamivir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- oxaliplatin
- oxaprozin
- Erythema multiforme
- Stevens-Johnson syndrome
- oxcarbazepine
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- paclitaxel
- Erythema multiforme: very rare, postmarketing, uncommon
- Stevens-Johnson syndrome: very rare, postmarketing, uncommon
- pantoprazole
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- parecoxib
- Erythema multiforme
- Stevens-Johnson syndrome
- paroxetine
- Erythema multiforme: very rare, rare
- Stevens-Johnson syndrome: very rare, postmarketing
- pemetrexed
- Erythema multiforme: common
- Stevens-Johnson syndrome: postmarketing
- penciclovir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- pentamidine
- pentazocine
- perindopril erbumine
- phenobarbital
- phenytoin
- piperacillin
- Erythema multiforme: rare
- Stevens-Johnson syndrome: very rare
- piroxicam
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome
- posaconazole
- pravastatin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- pregabalin
- Stevens-Johnson syndrome: rare
- probenecid
- prochlorperazine
- progesterone
- propranolol
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- pyrimethamine
- Erythema multiforme
- Stevens-Johnson syndrome
- quetiapine
- Stevens-Johnson syndrome: postmarketing
- quinidine
- Erythema multiforme
- Stevens-Johnson syndrome
- rabeprazole
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- raltegravir
- Stevens-Johnson syndrome: postmarketing
- ramipril
- Erythema multiforme
- Stevens-Johnson syndrome
- ramiprilat
- Erythema multiforme
- Stevens-Johnson syndrome
- ranitidine
- regorafenib
- Erythema multiforme
- Stevens-Johnson syndrome
- repaglinide
- retinoic acid
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- ribavirin
- Erythema multiforme: very rare
- Stevens-Johnson syndrome: very rare, postmarketing
- rifampicin
- Erythema multiforme
- Stevens-Johnson syndrome
- riluzole
- Erythema multiforme: rare
- risperidone
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- ritonavir
- rivaroxaban
- Stevens-Johnson syndrome: postmarketing
- rivastigmine
- Stevens-Johnson syndrome: postmarketing
- rofecoxib
- rosiglitazone
- Stevens-Johnson syndrome: postmarketing
- roxithromycin
- Erythema multiforme
- Stevens-Johnson syndrome
- salicylate
- saquinavir
- Stevens-Johnson syndrome: uncommon
- sertraline
- Erythema multiforme: rare
- Stevens-Johnson syndrome: postmarketing
- sildenafil
- Stevens-Johnson syndrome: postmarketing
- silver nanoparticles
- silver sulfadiazine
- Erythema multiforme
- Stevens-Johnson syndrome
- simvastatin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- sitagliptin
- Stevens-Johnson syndrome: postmarketing
- solifenacin
- Erythema multiforme: postmarketing
- sorafenib
- Erythema multiforme: uncommon
- Stevens-Johnson syndrome: postmarketing
- Erythema multiforme minor
- sparfloxacin
- Stevens-Johnson syndrome: postmarketing
- spironolactone
- strontium ranelate
- Stevens-Johnson syndrome: postmarketing
- sulfacetamide
- sulfadiazine
- Erythema multiforme
- Stevens-Johnson syndrome
- sulfamethoxazole
- Erythema multiforme
- Stevens-Johnson syndrome
- sulfasalazine
- Erythema multiforme
- Stevens-Johnson syndrome
- sulindac
- Erythema multiforme
- Stevens-Johnson syndrome
- sunitinib
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome
- tacrolimus
- Stevens-Johnson syndrome: very rare, postmarketing
- tadalafil
- Stevens-Johnson syndrome: postmarketing
- tamoxifen
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- tamsulosin
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- technetium-99m
- telithromycin
- Erythema multiforme
- Stevens-Johnson syndrome
- temozolomide
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: postmarketing
- temsirolimus
- Stevens-Johnson syndrome: postmarketing
- tenoxicam
- Stevens-Johnson syndrome: very rare
- terbinafine
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- thalidomide
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome
- thiabendazole
- Erythema multiforme
- Stevens-Johnson syndrome
- thiazide
- Erythema multiforme
- Stevens-Johnson syndrome
- tiaprofenic acid
- tibolone
- ticlopidine
- Erythema multiforme
- Stevens-Johnson syndrome
- tigecycline
- Stevens-Johnson syndrome: postmarketing
- tinidazole
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- tipranavir
- tizanidine
- Erythema multiforme
- Stevens-Johnson syndrome: postmarketing
- tolcapone
- Erythema multiforme: infrequent
- tolmetin
- topiramate
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- torasemide
- Stevens-Johnson syndrome: postmarketing
- tramadol
- Stevens-Johnson syndrome: postmarketing
- trandolapril
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- trandolaprilat
- Stevens-Johnson syndrome: postmarketing
- trimethadione
- trimethoprim
- Erythema multiforme: very rare
- Stevens-Johnson syndrome: very rare
- trimethoprim-sulfamethoxazole
- Erythema multiforme: very rare
- Stevens-Johnson syndrome: very rare
- trospium chloride
- Stevens-Johnson syndrome: postmarketing
- trovafloxacin
- Stevens-Johnson syndrome: postmarketing
- valdecoxib
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- valproate
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- vandetanib
- Erythema multiforme
- Stevens-Johnson syndrome
- varenicline
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- vemurafenib
- Stevens-Johnson syndrome: postmarketing, common
- venlafaxine
- Erythema multiforme: very rare, postmarketing
- Stevens-Johnson syndrome: very rare, postmarketing
- verapamil
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- vigabatrin
- Stevens-Johnson syndrome: postmarketing
- voriconazole
- Erythema multiforme: rare
- Stevens-Johnson syndrome: uncommon
- zanamivir
- Erythema multiforme: postmarketing
- Stevens-Johnson syndrome: postmarketing
- zidovudine
- Stevens-Johnson syndrome: postmarketing
- zonisamide
- Erythema multiforme
- Stevens-Johnson syndrome
- zopiclone
- Erythema multiforme: rare
|
Drugs with this indication
|